These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36878561)

  • 1. Update in the molecular classification of endometrial carcinoma.
    Léon-Castillo A
    Int J Gynecol Cancer; 2023 Mar; 33(3):333-342. PubMed ID: 36878561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
    McAlpine J; Leon-Castillo A; Bosse T
    J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of
    Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
    Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
    Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
    Talhouk A; Hoang LN; McConechy MK; Nakonechny Q; Leo J; Cheng A; Leung S; Yang W; Lum A; Köbel M; Lee CH; Soslow RA; Huntsman DG; Gilks CB; McAlpine JN
    Gynecol Oncol; 2016 Oct; 143(1):46-53. PubMed ID: 27421752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insights into the classification of high-grade endometrial carcinoma.
    Hussein YR; Soslow RA
    Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
    Zhang C; Zheng W
    Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
    Rau TT; Bettschen E; Büchi C; Christe L; Rohner A; Müller MD; Carlson JW; Imboden S; Zlobec I
    Mod Pathol; 2021 Jan; 34(1):222-232. PubMed ID: 32728223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome.
    Wadee R; Grayson W
    Ann Diagn Pathol; 2019 Apr; 39():92-104. PubMed ID: 30798077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinically applicable molecular-based classification for endometrial cancers.
    Talhouk A; McConechy MK; Leung S; Li-Chang HH; Kwon JS; Melnyk N; Yang W; Senz J; Boyd N; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
    Br J Cancer; 2015 Jul; 113(2):299-310. PubMed ID: 26172027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial Cancer: Transitioning from Histology to Genomics.
    Mitric C; Bernardini MQ
    Curr Oncol; 2022 Jan; 29(2):741-757. PubMed ID: 35200562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial Cancer: An Update on Prognostic Pathologic Features and Clinically Relevant Biomarkers.
    Li JJX; Ip PPC
    Surg Pathol Clin; 2022 Jun; 15(2):277-299. PubMed ID: 35715162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological and molecular classification of endometrial carcinoma and therapeutical implications].
    Genestie C; Leary A; Devouassoux M; Auguste A
    Bull Cancer; 2017 Dec; 104(12):1001-1012. PubMed ID: 29031505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of endometrial carcinoma: more than two types.
    Murali R; Soslow RA; Weigelt B
    Lancet Oncol; 2014 Jun; 15(7):e268-78. PubMed ID: 24872110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of molecular characteristics into endometrial cancer management.
    Vermij L; Smit V; Nout R; Bosse T
    Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
    Marnitz S; Waltar T; Köhler C; Mustea A; Schömig-Markiefka B
    Strahlenther Onkol; 2020 Nov; 196(11):963-972. PubMed ID: 32430662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
    Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
    Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mutation profiles to refine the classification of endometrial carcinomas.
    McConechy MK; Ding J; Cheang MC; Wiegand K; Senz J; Tone A; Yang W; Prentice L; Tse K; Zeng T; McDonald H; Schmidt AP; Mutch DG; McAlpine JN; Hirst M; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
    J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Genetics of Endometrial Carcinoma.
    Bell DW; Ellenson LH
    Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
    Wang M; Hui P
    Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.